tiprankstipranks
Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
Holding APGE?
Track your performance easily

Apogee Therapeutics, Inc. (APGE) Financial Statements

110 Followers

Apogee Therapeutics, Inc. Financial Overview

Apogee Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.727; its P/E ratio is -15.72; Apogee Therapeutics, Inc. is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-1.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -58.69M$ -44.12M$ -38.18M$ -20.84M-
EBITDA$ -62.14M$ -44.09M$ -38.15M$ -20.84M-
Net Income Common Stockholders$ -49.02M$ -33.82M$ -32.09M$ -20.84M$ -18.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 526.05M$ 676.23M$ 816.20M$ 422.85M$ 125.07M
Total Assets$ 776.29M$ 800.66M$ 823.66M$ 426.42M$ 130.67M
Total Debt$ 12.14M$ 4.08M$ 1.77M$ 0.00$ 0.00
Net Debt$ -513.91M$ -672.14M$ -814.42M$ -422.85M$ -125.07M
Total Liabilities$ 41.88M$ 27.02M$ 22.18M$ 17.18M$ 17.61M
Stockholders Equity$ 734.40M$ 773.64M$ 801.48M$ 409.24M$ 113.05M
Cash Flow-
Free Cash Flow$ -43.35M$ -29.35M$ -31.95M-$ -14.57M
Operating Cash Flow$ -42.60M$ -29.30M$ -31.60M$ -19.88M$ -14.57M
Investing Cash Flow$ -146.38M$ -148.71M$ -51.74M$ -234.22M-
Financing Cash Flow$ 383.00K$ -150.00K$ 450.52M$ 317.30M$ -1.69M
Currency in USD

Apogee Therapeutics, Inc. Earnings and Revenue History

Apogee Therapeutics, Inc. Debt to Assets

Apogee Therapeutics, Inc. Cash Flow

Apogee Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis